ApexiCon E (Diflorasone diacetate) for Eczema | MyEczemaTeam

Connect with others who understand.

sign up Log in
About MyEczemaTeam
Powered By

ApexiCon E is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat inflammation and itching associated with skin conditions that respond to corticosteroids. ApexiCon E is also known by its drug name, diflorasone diacetate.

ApexiCon E is a high-potency corticosteroid. ApexiCon E is believed to work by suppressing immune system activity.

How do I take it?
Prescribing information states that ApexiCon E is applied topically to the affected area one to three times daily.

ApexiCon E comes in the form of a cream.

Side effects
The FDA-approved label for ApexiCon E lists common side effects including burning, itching, redness, irritation, dryness, papular (raised) rashes, skin atrophy (thinning, wrinkling, or visible depressions in the skin), allergic contact dermatitis, secondary infection, stretch marks, hyperpigmentation (darkening skin color), and thickening of the skin.

Rare but serious side effects listed for corticosteroids include glaucoma, high blood sugar, and reversible hypothalamic-pituitary-adrenal axis suppression (a dysfunction of the adrenal system).

For more details about this treatment, visit:

ApexiCon E — ANI Pharmaceuticals

Prescription Topicals — National Eczema Association

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in